| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 80 | 2023 | 892 | 13.430 |
Why?
|
| Islets of Langerhans | 161 | 2023 | 1352 | 12.150 |
Why?
|
| Pancreatic Ducts | 25 | 2021 | 328 | 4.420 |
Why?
|
| Pancreas | 46 | 2017 | 1687 | 3.480 |
Why?
|
| Islets of Langerhans Transplantation | 67 | 2020 | 745 | 3.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 33 | 2023 | 3338 | 2.340 |
Why?
|
| Insulin | 110 | 2023 | 6582 | 2.200 |
Why?
|
| Diabetes Mellitus, Experimental | 57 | 2020 | 1115 | 2.010 |
Why?
|
| Regeneration | 25 | 2017 | 1485 | 2.010 |
Why?
|
| Maf Transcription Factors, Large | 9 | 2018 | 21 | 1.940 |
Why?
|
| Glucose | 41 | 2023 | 4398 | 1.910 |
Why?
|
| Insulin Resistance | 21 | 2023 | 3864 | 1.790 |
Why?
|
| Cell Differentiation | 42 | 2023 | 11486 | 1.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 39 | 2023 | 11726 | 1.400 |
Why?
|
| Triiodothyronine | 3 | 2018 | 494 | 1.400 |
Why?
|
| Glucagon | 28 | 2023 | 533 | 1.360 |
Why?
|
| Receptors, Glucagon | 5 | 2022 | 92 | 1.270 |
Why?
|
| Stem Cells | 21 | 2023 | 3567 | 1.240 |
Why?
|
| Diabetes Mellitus | 22 | 2023 | 5749 | 1.200 |
Why?
|
| Glucagon-Secreting Cells | 2 | 2023 | 41 | 1.030 |
Why?
|
| Hyperglycemia | 25 | 2023 | 1373 | 0.980 |
Why?
|
| Rats | 106 | 2023 | 24252 | 0.930 |
Why?
|
| Animals | 232 | 2023 | 168768 | 0.830 |
Why?
|
| Trans-Activators | 15 | 2016 | 2926 | 0.780 |
Why?
|
| Pancreatectomy | 29 | 2020 | 804 | 0.750 |
Why?
|
| Homeodomain Proteins | 16 | 2016 | 2418 | 0.740 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 290 | 0.710 |
Why?
|
| Rats, Sprague-Dawley | 44 | 2018 | 8300 | 0.670 |
Why?
|
| Cell Size | 7 | 2013 | 643 | 0.660 |
Why?
|
| Embryonic Stem Cells | 5 | 2015 | 1295 | 0.650 |
Why?
|
| Cell Division | 31 | 2010 | 4569 | 0.650 |
Why?
|
| Organoids | 3 | 2018 | 701 | 0.640 |
Why?
|
| Hypoglycemia | 4 | 2023 | 861 | 0.630 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2018 | 94 | 0.630 |
Why?
|
| Carbonic Anhydrase II | 2 | 2008 | 23 | 0.620 |
Why?
|
| Blood Glucose | 63 | 2023 | 6254 | 0.620 |
Why?
|
| Mice | 120 | 2022 | 81201 | 0.610 |
Why?
|
| SOX9 Transcription Factor | 1 | 2018 | 146 | 0.590 |
Why?
|
| Cell Transdifferentiation | 4 | 2013 | 172 | 0.560 |
Why?
|
| Pancreas, Exocrine | 3 | 2015 | 45 | 0.560 |
Why?
|
| Animals, Newborn | 23 | 2014 | 2726 | 0.540 |
Why?
|
| Cell Growth Processes | 2 | 2013 | 399 | 0.510 |
Why?
|
| Venoms | 6 | 2013 | 91 | 0.510 |
Why?
|
| Glucagon-Like Peptide 1 | 6 | 2013 | 340 | 0.500 |
Why?
|
| Cell Proliferation | 16 | 2018 | 10483 | 0.500 |
Why?
|
| Incretins | 2 | 2014 | 88 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2013 | 71 | 0.440 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 135 | 0.440 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2016 | 472 | 0.430 |
Why?
|
| Epithelial Cells | 10 | 2018 | 3690 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 31 | 2019 | 21833 | 0.390 |
Why?
|
| Apoptosis | 19 | 2022 | 9724 | 0.380 |
Why?
|
| Microdissection | 6 | 2011 | 152 | 0.380 |
Why?
|
| Tissue Engineering | 5 | 2013 | 1880 | 0.370 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2015 | 4751 | 0.360 |
Why?
|
| Keratin-19 | 1 | 2010 | 33 | 0.360 |
Why?
|
| Stem Cell Transplantation | 3 | 2010 | 1620 | 0.360 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2010 | 49 | 0.360 |
Why?
|
| Cell Culture Techniques | 9 | 2014 | 1678 | 0.340 |
Why?
|
| Streptozocin | 10 | 2013 | 196 | 0.340 |
Why?
|
| beta-Galactosidase | 3 | 2008 | 574 | 0.340 |
Why?
|
| Humans | 116 | 2023 | 744366 | 0.330 |
Why?
|
| Multipotent Stem Cells | 2 | 2013 | 186 | 0.330 |
Why?
|
| Mice, Transgenic | 21 | 2015 | 9735 | 0.330 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2017 | 3617 | 0.320 |
Why?
|
| Pyrrolidines | 1 | 2010 | 342 | 0.320 |
Why?
|
| RNA, Messenger | 27 | 2023 | 13035 | 0.310 |
Why?
|
| Protein Transport | 5 | 2013 | 1988 | 0.300 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2007 | 38 | 0.300 |
Why?
|
| Peptides | 9 | 2023 | 4410 | 0.300 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 2 | 2013 | 293 | 0.300 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 9 | 2015 | 1115 | 0.290 |
Why?
|
| Monosaccharide Transport Proteins | 9 | 2002 | 440 | 0.290 |
Why?
|
| Green Fluorescent Proteins | 6 | 2017 | 2088 | 0.280 |
Why?
|
| Transplantation, Heterologous | 13 | 2010 | 2383 | 0.280 |
Why?
|
| Cells, Cultured | 20 | 2019 | 19233 | 0.280 |
Why?
|
| Cyclin A | 2 | 2005 | 60 | 0.280 |
Why?
|
| Cell Lineage | 7 | 2016 | 2504 | 0.270 |
Why?
|
| Cell Separation | 6 | 2010 | 1751 | 0.270 |
Why?
|
| MafB Transcription Factor | 3 | 2013 | 25 | 0.270 |
Why?
|
| Endosomes | 2 | 2005 | 519 | 0.260 |
Why?
|
| Cell Count | 12 | 2010 | 1856 | 0.260 |
Why?
|
| Genes, Reporter | 7 | 2013 | 1547 | 0.260 |
Why?
|
| Transcription Factors | 15 | 2015 | 12207 | 0.260 |
Why?
|
| Cell Line | 10 | 2011 | 16000 | 0.260 |
Why?
|
| Nitriles | 1 | 2010 | 955 | 0.260 |
Why?
|
| Oxidative Stress | 5 | 2009 | 3084 | 0.250 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2018 | 202 | 0.250 |
Why?
|
| Gene Expression Regulation | 19 | 2014 | 12073 | 0.250 |
Why?
|
| Genes, myc | 3 | 2002 | 399 | 0.250 |
Why?
|
| Somatostatin | 16 | 2009 | 459 | 0.250 |
Why?
|
| Cell Nucleus | 5 | 2023 | 2969 | 0.240 |
Why?
|
| Endocrine Cells | 3 | 2015 | 10 | 0.240 |
Why?
|
| Mice, Inbred NOD | 10 | 2022 | 1879 | 0.210 |
Why?
|
| Flow Cytometry | 5 | 2019 | 5974 | 0.210 |
Why?
|
| Body Weight | 21 | 2019 | 4671 | 0.210 |
Why?
|
| Stress, Physiological | 4 | 2022 | 1403 | 0.210 |
Why?
|
| Endocytosis | 3 | 2005 | 985 | 0.210 |
Why?
|
| DNA-Binding Proteins | 10 | 2009 | 9647 | 0.210 |
Why?
|
| Alginates | 6 | 2011 | 252 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 11 | 2015 | 4463 | 0.200 |
Why?
|
| Male | 114 | 2020 | 350115 | 0.200 |
Why?
|
| Rats, Inbred Lew | 13 | 2020 | 1162 | 0.190 |
Why?
|
| Keratins | 4 | 2016 | 515 | 0.190 |
Why?
|
| Culture Techniques | 2 | 2001 | 554 | 0.190 |
Why?
|
| Fetal Tissue Transplantation | 2 | 1998 | 139 | 0.190 |
Why?
|
| Iodide Peroxidase | 2 | 2013 | 293 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2018 | 705 | 0.180 |
Why?
|
| Cadaver | 3 | 2013 | 1337 | 0.180 |
Why?
|
| Transduction, Genetic | 4 | 2009 | 913 | 0.170 |
Why?
|
| Cell Aggregation | 6 | 2010 | 244 | 0.170 |
Why?
|
| Cell Transplantation | 3 | 2012 | 477 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 9 | 2013 | 5867 | 0.170 |
Why?
|
| Rats, Inbred Strains | 17 | 1991 | 2186 | 0.170 |
Why?
|
| Gene Expression Profiling | 11 | 2017 | 9445 | 0.170 |
Why?
|
| Models, Biological | 12 | 2017 | 9584 | 0.170 |
Why?
|
| Signal Transduction | 9 | 2022 | 23404 | 0.160 |
Why?
|
| Swine | 14 | 2014 | 5918 | 0.160 |
Why?
|
| Integrin alphaV | 1 | 2018 | 55 | 0.160 |
Why?
|
| Down-Regulation | 4 | 2020 | 3001 | 0.160 |
Why?
|
| Cell Death | 7 | 2013 | 1707 | 0.150 |
Why?
|
| Hemolytic Plaque Technique | 1 | 2017 | 66 | 0.150 |
Why?
|
| Remission Induction | 1 | 2023 | 2385 | 0.150 |
Why?
|
| Phagocytosis | 2 | 2022 | 1539 | 0.150 |
Why?
|
| Staining and Labeling | 3 | 2014 | 1101 | 0.150 |
Why?
|
| Graft Survival | 9 | 2009 | 3737 | 0.150 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 440 | 0.150 |
Why?
|
| Liver | 11 | 2011 | 7475 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2011 | 3921 | 0.140 |
Why?
|
| Adenoviridae | 6 | 2009 | 1101 | 0.140 |
Why?
|
| Capsules | 7 | 2011 | 196 | 0.140 |
Why?
|
| Pancreatic Polypeptide | 8 | 2013 | 34 | 0.130 |
Why?
|
| Gastrins | 4 | 2013 | 81 | 0.130 |
Why?
|
| Carbonic Anhydrases | 1 | 2016 | 115 | 0.130 |
Why?
|
| Ki-67 Antigen | 2 | 2014 | 644 | 0.130 |
Why?
|
| Cell Survival | 8 | 2013 | 5882 | 0.130 |
Why?
|
| NAD | 1 | 1999 | 590 | 0.130 |
Why?
|
| Glucose Tolerance Test | 15 | 2011 | 1151 | 0.130 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 234 | 0.130 |
Why?
|
| Glucose Transporter Type 2 | 6 | 2015 | 62 | 0.130 |
Why?
|
| Mice, Nude | 10 | 2005 | 3689 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2018 | 4222 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1677 | 0.120 |
Why?
|
| Glucose Clamp Technique | 3 | 2019 | 266 | 0.120 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 390 | 0.120 |
Why?
|
| Gene Expression | 13 | 2020 | 7798 | 0.120 |
Why?
|
| Angiopoietins | 1 | 2014 | 80 | 0.120 |
Why?
|
| Aniline Compounds | 1 | 2019 | 986 | 0.120 |
Why?
|
| Adult | 22 | 2018 | 214052 | 0.120 |
Why?
|
| Immunohistochemistry | 9 | 2015 | 11366 | 0.120 |
Why?
|
| Time Factors | 24 | 2019 | 40075 | 0.120 |
Why?
|
| Aging | 8 | 2017 | 8664 | 0.120 |
Why?
|
| Pancreatic Diseases | 2 | 2013 | 350 | 0.120 |
Why?
|
| Disease Progression | 5 | 2021 | 13286 | 0.120 |
Why?
|
| HeLa Cells | 6 | 2006 | 3130 | 0.120 |
Why?
|
| Epithelium | 2 | 2015 | 1679 | 0.120 |
Why?
|
| Tumor Necrosis Factors | 1 | 2013 | 109 | 0.110 |
Why?
|
| Protein Precursors | 3 | 2005 | 1154 | 0.110 |
Why?
|
| Microscopy, Electron | 5 | 2010 | 2646 | 0.110 |
Why?
|
| Endothelial Growth Factors | 3 | 2001 | 694 | 0.110 |
Why?
|
| Hormones | 2 | 2016 | 889 | 0.110 |
Why?
|
| Recombinant Proteins | 7 | 2013 | 6621 | 0.110 |
Why?
|
| Cell Polarity | 1 | 2016 | 645 | 0.110 |
Why?
|
| Embryonic and Fetal Development | 1 | 1993 | 438 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2008 | 3309 | 0.110 |
Why?
|
| Rats, Zucker | 5 | 2013 | 128 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 1213 | 0.110 |
Why?
|
| Lymphokines | 3 | 2001 | 949 | 0.110 |
Why?
|
| Arginine | 9 | 2005 | 944 | 0.110 |
Why?
|
| Mice, Inbred ICR | 2 | 2010 | 352 | 0.110 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 252 | 0.110 |
Why?
|
| Molecular Chaperones | 2 | 2001 | 743 | 0.100 |
Why?
|
| Mice, Inbred Strains | 12 | 2006 | 1828 | 0.100 |
Why?
|
| Pancreas Transplantation | 2 | 2003 | 187 | 0.100 |
Why?
|
| C-Peptide | 5 | 2019 | 419 | 0.100 |
Why?
|
| Female | 41 | 2019 | 380193 | 0.100 |
Why?
|
| Chromatin | 1 | 2023 | 2933 | 0.100 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2011 | 39 | 0.100 |
Why?
|
| Protein Kinase C | 3 | 2007 | 1227 | 0.100 |
Why?
|
| Malate Dehydrogenase | 1 | 2011 | 41 | 0.100 |
Why?
|
| Dithizone | 1 | 2010 | 2 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2010 | 9 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 1085 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2006 | 7721 | 0.100 |
Why?
|
| Lasers | 3 | 2010 | 952 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 6 | 2007 | 6171 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 1121 | 0.090 |
Why?
|
| Cyclic AMP Response Element Modulator | 3 | 2005 | 87 | 0.090 |
Why?
|
| Expressed Sequence Tags | 1 | 2011 | 255 | 0.090 |
Why?
|
| Adaptation, Physiological | 5 | 2002 | 1312 | 0.090 |
Why?
|
| Amyloid | 3 | 2008 | 795 | 0.090 |
Why?
|
| Protein Denaturation | 1 | 2010 | 237 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 2 | 2007 | 214 | 0.090 |
Why?
|
| Glucokinase | 4 | 2003 | 103 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 3 | 2008 | 1081 | 0.090 |
Why?
|
| Organ Size | 7 | 2002 | 2251 | 0.090 |
Why?
|
| Isoenzymes | 2 | 2007 | 1728 | 0.090 |
Why?
|
| Peptide Fragments | 4 | 2005 | 5096 | 0.090 |
Why?
|
| Silicon | 1 | 2010 | 145 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2019 | 1940 | 0.090 |
Why?
|
| Aspartate Aminotransferases | 1 | 2011 | 418 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2010 | 5181 | 0.090 |
Why?
|
| Postpartum Period | 1 | 1995 | 1086 | 0.080 |
Why?
|
| Ligands | 1 | 2016 | 3282 | 0.080 |
Why?
|
| Antigens, Differentiation | 2 | 2004 | 927 | 0.080 |
Why?
|
| Models, Animal | 4 | 2004 | 2173 | 0.080 |
Why?
|
| Autopsy | 1 | 2013 | 1020 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 2 | 2023 | 5263 | 0.080 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2008 | 18 | 0.080 |
Why?
|
| Middle Aged | 16 | 2019 | 213390 | 0.080 |
Why?
|
| Growth Substances | 2 | 2001 | 784 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 3 | 2004 | 2007 | 0.080 |
Why?
|
| Mitosis | 4 | 2002 | 1208 | 0.080 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2008 | 449 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2013 | 2499 | 0.080 |
Why?
|
| Microscopy | 2 | 2010 | 902 | 0.080 |
Why?
|
| Random Allocation | 1 | 2013 | 2428 | 0.080 |
Why?
|
| Transcriptional Activation | 3 | 2004 | 1783 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2016 | 2751 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2009 | 697 | 0.080 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2008 | 163 | 0.080 |
Why?
|
| Immunomodulation | 1 | 2012 | 541 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2013 | 1730 | 0.080 |
Why?
|
| DNA Primers | 7 | 2009 | 2891 | 0.080 |
Why?
|
| Phosphoproteins | 4 | 2007 | 2441 | 0.080 |
Why?
|
| Transgenes | 2 | 2008 | 1009 | 0.080 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2009 | 295 | 0.080 |
Why?
|
| Epidermal Growth Factor | 2 | 2013 | 709 | 0.070 |
Why?
|
| Transforming Growth Factor alpha | 2 | 2000 | 135 | 0.070 |
Why?
|
| Transfection | 7 | 2006 | 5895 | 0.070 |
Why?
|
| CA-19-9 Antigen | 1 | 2007 | 112 | 0.070 |
Why?
|
| Cloning, Molecular | 4 | 2009 | 4320 | 0.070 |
Why?
|
| Palmitic Acid | 2 | 2022 | 154 | 0.070 |
Why?
|
| src-Family Kinases | 1 | 2009 | 551 | 0.070 |
Why?
|
| Animals, Suckling | 1 | 2006 | 72 | 0.070 |
Why?
|
| Aged | 12 | 2019 | 163288 | 0.070 |
Why?
|
| Repressor Proteins | 3 | 2007 | 3024 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1613 | 0.070 |
Why?
|
| RNA | 5 | 2009 | 2749 | 0.070 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 18034 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2002 | 988 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2007 | 473 | 0.070 |
Why?
|
| Glucose Intolerance | 4 | 2007 | 577 | 0.070 |
Why?
|
| Cell Communication | 3 | 1990 | 1621 | 0.070 |
Why?
|
| Vimentin | 2 | 2004 | 262 | 0.070 |
Why?
|
| Awards and Prizes | 1 | 2010 | 375 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2002 | 5445 | 0.070 |
Why?
|
| Embryo, Mammalian | 3 | 2007 | 1701 | 0.070 |
Why?
|
| Transplantation, Heterotopic | 5 | 1997 | 175 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2010 | 3773 | 0.060 |
Why?
|
| Neurons | 1 | 2004 | 9340 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2001 | 2016 | 0.060 |
Why?
|
| DNA | 11 | 2011 | 7294 | 0.060 |
Why?
|
| Immunoconjugates | 2 | 2004 | 901 | 0.060 |
Why?
|
| Oxygen | 3 | 2010 | 4189 | 0.060 |
Why?
|
| Obesity | 7 | 2012 | 12746 | 0.060 |
Why?
|
| Dexamethasone | 5 | 2007 | 1951 | 0.060 |
Why?
|
| Mice, Knockout | 9 | 2013 | 14561 | 0.060 |
Why?
|
| Eye Proteins | 1 | 2007 | 645 | 0.060 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2007 | 270 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 1996 | 3589 | 0.060 |
Why?
|
| Hepatocytes | 2 | 2008 | 1211 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2004 | 1472 | 0.060 |
Why?
|
| Korea | 1 | 2003 | 99 | 0.060 |
Why?
|
| Cattle | 5 | 2001 | 3922 | 0.050 |
Why?
|
| Stearic Acids | 1 | 2022 | 53 | 0.050 |
Why?
|
| Immunocompetence | 1 | 2003 | 136 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 2 | 2000 | 1351 | 0.050 |
Why?
|
| Oxidoreductases | 2 | 2002 | 424 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2005 | 697 | 0.050 |
Why?
|
| Bariatric Surgery | 1 | 2012 | 952 | 0.050 |
Why?
|
| Reference Values | 8 | 2001 | 4982 | 0.050 |
Why?
|
| Genetic Vectors | 4 | 2006 | 3424 | 0.050 |
Why?
|
| Fatty Acids | 2 | 2008 | 1809 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2003 | 251 | 0.050 |
Why?
|
| Metabolic Diseases | 1 | 2009 | 658 | 0.050 |
Why?
|
| Adolescent | 6 | 2019 | 85779 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 895 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2008 | 796 | 0.050 |
Why?
|
| Lentivirus | 1 | 2004 | 503 | 0.050 |
Why?
|
| Autoantibodies | 3 | 2019 | 2036 | 0.050 |
Why?
|
| Hexuronic Acids | 3 | 2011 | 144 | 0.050 |
Why?
|
| Hexosamines | 1 | 2001 | 44 | 0.050 |
Why?
|
| Glucuronic Acid | 3 | 2011 | 148 | 0.050 |
Why?
|
| Autophagy | 1 | 2009 | 1297 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 6 | 1998 | 257 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 1284 | 0.050 |
Why?
|
| Spleen | 2 | 2006 | 2362 | 0.050 |
Why?
|
| Histocytochemistry | 3 | 2006 | 719 | 0.050 |
Why?
|
| Receptor, Insulin | 3 | 2007 | 847 | 0.050 |
Why?
|
| Myelin P2 Protein | 1 | 2000 | 20 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2010 | 2585 | 0.050 |
Why?
|
| Kidney | 6 | 2006 | 7184 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 2008 | 2865 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2006 | 851 | 0.050 |
Why?
|
| Eating | 4 | 2001 | 1536 | 0.050 |
Why?
|
| Lysine | 1 | 2005 | 1007 | 0.050 |
Why?
|
| Fats | 1 | 2001 | 102 | 0.050 |
Why?
|
| Microcirculation | 3 | 1999 | 1287 | 0.050 |
Why?
|
| Young Adult | 3 | 2017 | 56429 | 0.050 |
Why?
|
| Diffusion Chambers, Culture | 2 | 1998 | 50 | 0.050 |
Why?
|
| Phosphatidylserines | 1 | 2022 | 193 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2008 | 2740 | 0.050 |
Why?
|
| Muscle Proteins | 2 | 1996 | 1158 | 0.050 |
Why?
|
| Graft Rejection | 3 | 2006 | 4397 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 1736 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 2765 | 0.050 |
Why?
|
| Inhibins | 1 | 2001 | 211 | 0.050 |
Why?
|
| Retroviridae | 1 | 2003 | 914 | 0.050 |
Why?
|
| Rabbits | 2 | 2006 | 4894 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 381 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 4 | 2010 | 1146 | 0.050 |
Why?
|
| Receptors, Growth Factor | 1 | 2001 | 334 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2004 | 3707 | 0.040 |
Why?
|
| Phagocytes | 1 | 2022 | 297 | 0.040 |
Why?
|
| Morphogenesis | 2 | 2001 | 751 | 0.040 |
Why?
|
| Laminin | 3 | 2010 | 419 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2007 | 1195 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 644 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 1335 | 0.040 |
Why?
|
| Fructose | 1 | 2001 | 289 | 0.040 |
Why?
|
| Insulin Antibodies | 2 | 1989 | 31 | 0.040 |
Why?
|
| Activins | 1 | 2001 | 208 | 0.040 |
Why?
|
| Receptors, Cholecystokinin | 1 | 1999 | 18 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 4 | 2007 | 563 | 0.040 |
Why?
|
| Electrochemistry | 1 | 1999 | 145 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2000 | 336 | 0.040 |
Why?
|
| Subtilisins | 1 | 1999 | 83 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1999 | 177 | 0.040 |
Why?
|
| Adenoviridae Infections | 1 | 1999 | 96 | 0.040 |
Why?
|
| HLA-A Antigens | 1 | 2019 | 232 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 5 | 2010 | 6386 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2007 | 2016 | 0.040 |
Why?
|
| Pancreas, Artificial | 1 | 1999 | 54 | 0.040 |
Why?
|
| Cell Membrane | 1 | 1988 | 3749 | 0.040 |
Why?
|
| Tissue Donors | 2 | 2010 | 2241 | 0.040 |
Why?
|
| HLA-DR Antigens | 2 | 2010 | 645 | 0.040 |
Why?
|
| Kinetics | 4 | 2010 | 6476 | 0.040 |
Why?
|
| Diffusion | 3 | 2011 | 832 | 0.040 |
Why?
|
| Corticosterone | 1 | 1999 | 310 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 2850 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2005 | 984 | 0.040 |
Why?
|
| Pituitary Hormones | 1 | 1999 | 183 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 599 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 853 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 6313 | 0.040 |
Why?
|
| Homeostasis | 4 | 2001 | 3339 | 0.040 |
Why?
|
| Cushing Syndrome | 1 | 1999 | 249 | 0.040 |
Why?
|
| Muscles | 3 | 2011 | 1614 | 0.040 |
Why?
|
| Hyperplasia | 3 | 2005 | 1185 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2001 | 822 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1999 | 648 | 0.040 |
Why?
|
| Gastric Bypass | 1 | 2005 | 812 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2000 | 369 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2001 | 850 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 2988 | 0.040 |
Why?
|
| Luciferases | 2 | 2009 | 733 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2001 | 905 | 0.040 |
Why?
|
| Hypoglycemic Agents | 3 | 2008 | 2873 | 0.040 |
Why?
|
| Food, Formulated | 2 | 2001 | 109 | 0.030 |
Why?
|
| Autoimmunity | 2 | 2007 | 1350 | 0.030 |
Why?
|
| Hydrogels | 1 | 2001 | 724 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 5 | 1994 | 1799 | 0.030 |
Why?
|
| Inflammation | 3 | 2017 | 10637 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 1999 | 553 | 0.030 |
Why?
|
| Clusterin | 1 | 1995 | 72 | 0.030 |
Why?
|
| Base Sequence | 5 | 2006 | 12797 | 0.030 |
Why?
|
| Hypertrophy | 2 | 2005 | 569 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 13814 | 0.030 |
Why?
|
| Endocrine System | 1 | 2015 | 113 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2014 | 124 | 0.030 |
Why?
|
| Lipid Metabolism | 2 | 2000 | 1889 | 0.030 |
Why?
|
| Muscle, Skeletal | 4 | 2001 | 4925 | 0.030 |
Why?
|
| Microscopy, Confocal | 3 | 2009 | 1970 | 0.030 |
Why?
|
| Adipose Tissue | 5 | 2011 | 3280 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1998 | 2505 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2001 | 772 | 0.030 |
Why?
|
| Salicylic Acid | 1 | 2013 | 56 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2004 | 4153 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 18111 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 2126 | 0.030 |
Why?
|
| Brain Death | 1 | 2017 | 348 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1660 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2010 | 2716 | 0.030 |
Why?
|
| Diet | 1 | 2011 | 7937 | 0.030 |
Why?
|
| Pregnancy | 5 | 2015 | 29144 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 1998 | 898 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 1998 | 951 | 0.030 |
Why?
|
| Ligation | 1 | 2013 | 453 | 0.030 |
Why?
|
| Age of Onset | 2 | 2010 | 3270 | 0.030 |
Why?
|
| Proteoglycans | 2 | 2010 | 837 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 2949 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2003 | 2897 | 0.030 |
Why?
|
| Proteins | 4 | 2002 | 6100 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2006 | 35425 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1991 | 116 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 3 | 1986 | 102 | 0.030 |
Why?
|
| Phylogeny | 1 | 1979 | 2804 | 0.030 |
Why?
|
| Triglycerides | 2 | 2014 | 2453 | 0.020 |
Why?
|
| Immunologic Techniques | 2 | 1996 | 219 | 0.020 |
Why?
|
| Hyperinsulinism | 2 | 2010 | 415 | 0.020 |
Why?
|
| Prediabetic State | 3 | 1992 | 499 | 0.020 |
Why?
|
| Vanadium | 1 | 1991 | 53 | 0.020 |
Why?
|
| Octoxynol | 1 | 2011 | 77 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2001 | 3759 | 0.020 |
Why?
|
| Transplantation, Homologous | 3 | 2007 | 4777 | 0.020 |
Why?
|
| Lactate Dehydrogenases | 1 | 2010 | 26 | 0.020 |
Why?
|
| Organ Culture Techniques | 2 | 2005 | 813 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2432 | 0.020 |
Why?
|
| Numismatics | 1 | 2010 | 17 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2013 | 595 | 0.020 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2010 | 79 | 0.020 |
Why?
|
| Politics | 1 | 1997 | 791 | 0.020 |
Why?
|
| Edetic Acid | 1 | 2011 | 275 | 0.020 |
Why?
|
| Mutagenesis | 2 | 2007 | 1264 | 0.020 |
Why?
|
| Phlorhizin | 2 | 2001 | 37 | 0.020 |
Why?
|
| Species Specificity | 1 | 1995 | 2478 | 0.020 |
Why?
|
| Autoradiography | 1 | 1991 | 745 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2013 | 16690 | 0.020 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2010 | 58 | 0.020 |
Why?
|
| Necrosis | 2 | 2010 | 1643 | 0.020 |
Why?
|
| Static Electricity | 1 | 2011 | 263 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 2001 | 5023 | 0.020 |
Why?
|
| DNA Probes | 1 | 1991 | 560 | 0.020 |
Why?
|
| Chickens | 2 | 2010 | 865 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2010 | 254 | 0.020 |
Why?
|
| Drug Combinations | 2 | 2010 | 1958 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2010 | 210 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2010 | 112 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 713 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1375 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 3508 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 1868 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1990 | 302 | 0.020 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2009 | 28 | 0.020 |
Why?
|
| Proinsulin | 3 | 1985 | 133 | 0.020 |
Why?
|
| Collagenases | 1 | 2009 | 228 | 0.020 |
Why?
|
| Immune Tolerance | 2 | 2008 | 2259 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1989 | 419 | 0.020 |
Why?
|
| Oleic Acid | 1 | 2008 | 85 | 0.020 |
Why?
|
| Tissue Preservation | 1 | 2009 | 182 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4554 | 0.020 |
Why?
|
| Temperature | 1 | 2014 | 2204 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 741 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2010 | 431 | 0.020 |
Why?
|
| Mitotic Index | 1 | 1988 | 172 | 0.020 |
Why?
|
| Symporters | 1 | 2010 | 361 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1987 | 115 | 0.020 |
Why?
|
| Biological Assay | 1 | 2011 | 652 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1995 | 2266 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2008 | 210 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2008 | 194 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 10943 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2007 | 91 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 867 | 0.020 |
Why?
|
| Glutamine | 1 | 1990 | 579 | 0.020 |
Why?
|
| Phosphorylation | 3 | 2007 | 8436 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 430 | 0.020 |
Why?
|
| Antigens, CD | 3 | 2004 | 4026 | 0.020 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 5856 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1987 | 122 | 0.020 |
Why?
|
| Collagen | 2 | 2010 | 2688 | 0.020 |
Why?
|
| Heterozygote | 3 | 1998 | 2804 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2009 | 961 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2007 | 184 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 150 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2013 | 1092 | 0.020 |
Why?
|
| Membranes, Artificial | 2 | 1999 | 378 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2007 | 224 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2700 | 0.020 |
Why?
|
| Fibronectins | 1 | 2010 | 726 | 0.020 |
Why?
|
| Dumping Syndrome | 1 | 2005 | 18 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 2003 | 2027 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6366 | 0.020 |
Why?
|
| Polyvinyl Alcohol | 2 | 1996 | 74 | 0.020 |
Why?
|
| Diazoxide | 1 | 2005 | 57 | 0.020 |
Why?
|
| Ischemia | 1 | 2014 | 1907 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2002 | 3702 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 2011 | 452 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 2008 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 2 | 1996 | 250 | 0.020 |
Why?
|
| Pinocytosis | 1 | 2005 | 65 | 0.020 |
Why?
|
| Mice, Obese | 2 | 2000 | 425 | 0.020 |
Why?
|
| Culture Media | 2 | 2001 | 909 | 0.020 |
Why?
|
| Drug Synergism | 2 | 1989 | 1794 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2003 | 12721 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2005 | 103 | 0.020 |
Why?
|
| Molecular Probe Techniques | 1 | 2006 | 119 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1993 | 1741 | 0.020 |
Why?
|
| Epigenomics | 1 | 2010 | 903 | 0.020 |
Why?
|
| Octreotide | 1 | 2005 | 145 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2006 | 360 | 0.020 |
Why?
|
| Homozygote | 2 | 2001 | 1787 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2005 | 174 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2005 | 140 | 0.020 |
Why?
|
| Mutation | 1 | 2009 | 29786 | 0.020 |
Why?
|
| Oxides | 1 | 2006 | 405 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2001 | 3511 | 0.020 |
Why?
|
| Polyglycolic Acid | 2 | 1996 | 407 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 203 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2006 | 321 | 0.020 |
Why?
|
| Diet Therapy | 1 | 2005 | 154 | 0.020 |
Why?
|
| Dextrans | 1 | 2006 | 595 | 0.020 |
Why?
|
| Chronic Disease | 5 | 2002 | 9145 | 0.020 |
Why?
|
| Family Health | 1 | 2009 | 1281 | 0.020 |
Why?
|
| Perfusion | 3 | 1998 | 1360 | 0.010 |
Why?
|
| Intercellular Junctions | 2 | 1986 | 203 | 0.010 |
Why?
|
| Infrared Rays | 1 | 2005 | 249 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 2003 | 70 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2007 | 675 | 0.010 |
Why?
|
| Fasting | 2 | 2001 | 1592 | 0.010 |
Why?
|
| Dogs | 1 | 1988 | 3912 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 10183 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2009 | 2124 | 0.010 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2003 | 73 | 0.010 |
Why?
|
| Mice, Mutant Strains | 2 | 2001 | 1865 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2439 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 563 | 0.010 |
Why?
|
| Weight Gain | 1 | 2013 | 2293 | 0.010 |
Why?
|
| Clodronic Acid | 1 | 2003 | 60 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 758 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3144 | 0.010 |
Why?
|
| Actins | 1 | 2010 | 2121 | 0.010 |
Why?
|
| Albumins | 1 | 2005 | 568 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 2002 | 179 | 0.010 |
Why?
|
| Tissue and Organ Procurement | 1 | 2010 | 896 | 0.010 |
Why?
|
| Tolbutamide | 1 | 1981 | 23 | 0.010 |
Why?
|
| Electrophoresis | 1 | 2002 | 240 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2004 | 405 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2967 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3848 | 0.010 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 1 | 2001 | 10 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 156 | 0.010 |
Why?
|
| Activating Transcription Factors | 1 | 2001 | 29 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1101 | 0.010 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2001 | 20 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 122 | 0.010 |
Why?
|
| Pedigree | 1 | 2009 | 4642 | 0.010 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2001 | 9 | 0.010 |
Why?
|
| Transcription Factor CHOP | 1 | 2001 | 73 | 0.010 |
Why?
|
| Theophylline | 1 | 1981 | 132 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 1629 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1981 | 399 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 1144 | 0.010 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2001 | 86 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 3 | 2001 | 9274 | 0.010 |
Why?
|
| Insulin Infusion Systems | 1 | 2002 | 212 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 275 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 4185 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1982 | 963 | 0.010 |
Why?
|
| APUD Cells | 1 | 1980 | 6 | 0.010 |
Why?
|
| RNA Interference | 1 | 2009 | 2890 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2007 | 1904 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2000 | 90 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 2001 | 183 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 452 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2001 | 198 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 534 | 0.010 |
Why?
|
| Keratin-7 | 1 | 1999 | 57 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2001 | 286 | 0.010 |
Why?
|
| Sirolimus | 1 | 2007 | 1565 | 0.010 |
Why?
|
| Ganglia | 1 | 1980 | 89 | 0.010 |
Why?
|
| Reptiles | 1 | 1979 | 9 | 0.010 |
Why?
|
| Pancreatic Hormones | 1 | 1999 | 13 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 3130 | 0.010 |
Why?
|
| Linear Models | 1 | 2010 | 5953 | 0.010 |
Why?
|
| Neuroendocrine Secretory Protein 7B2 | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proprotein Convertase 2 | 1 | 1999 | 11 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39052 | 0.010 |
Why?
|
| Amphibians | 1 | 1979 | 30 | 0.010 |
Why?
|
| Liposomes | 1 | 2003 | 759 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2005 | 1050 | 0.010 |
Why?
|
| Lipids | 2 | 2008 | 3307 | 0.010 |
Why?
|
| Receptor, Cholecystokinin A | 1 | 1999 | 13 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2001 | 2916 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2001 | 414 | 0.010 |
Why?
|
| Lipolysis | 1 | 2000 | 210 | 0.010 |
Why?
|
| Lac Operon | 1 | 1999 | 238 | 0.010 |
Why?
|
| Phenotype | 2 | 2010 | 16367 | 0.010 |
Why?
|
| Macrophages | 1 | 1994 | 5660 | 0.010 |
Why?
|
| Niacinamide | 1 | 2001 | 416 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 915 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 1998 | 27 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 1999 | 114 | 0.010 |
Why?
|
| Birds | 1 | 1979 | 163 | 0.010 |
Why?
|
| Biocompatible Materials | 2 | 1998 | 1736 | 0.010 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2000 | 300 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3873 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1999 | 318 | 0.010 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1999 | 163 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1980 | 410 | 0.010 |
Why?
|
| Light | 1 | 2004 | 1374 | 0.010 |
Why?
|
| Iron | 1 | 2006 | 1774 | 0.010 |
Why?
|
| Glycosylation | 1 | 2001 | 1128 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1999 | 552 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2001 | 321 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 552 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 1998 | 147 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 1917 | 0.010 |
Why?
|
| Protein Folding | 1 | 2001 | 840 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2001 | 664 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2005 | 2166 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2005 | 2480 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 1225 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5524 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2013 | 63107 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1999 | 402 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 3505 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1723 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1999 | 279 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2001 | 627 | 0.010 |
Why?
|
| Child | 2 | 2019 | 77709 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1980 | 610 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2008 | 3476 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1980 | 574 | 0.010 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 1996 | 41 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 57776 | 0.010 |
Why?
|
| Cadherins | 1 | 2001 | 907 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 2919 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 4666 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 655 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2274 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2001 | 1124 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2000 | 578 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1996 | 319 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 871 | 0.010 |
Why?
|
| Fishes | 1 | 1979 | 569 | 0.010 |
Why?
|
| Death | 1 | 2001 | 678 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2001 | 1842 | 0.010 |
Why?
|
| Action Potentials | 1 | 2003 | 1806 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1995 | 148 | 0.010 |
Why?
|
| Lithostathine | 1 | 1994 | 5 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1996 | 642 | 0.010 |
Why?
|
| Densitometry | 1 | 1995 | 156 | 0.010 |
Why?
|
| Epididymis | 1 | 1996 | 227 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2001 | 1318 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2010 | 3751 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1999 | 1475 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1998 | 880 | 0.010 |
Why?
|
| Nanoparticles | 1 | 2006 | 1905 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2000 | 2634 | 0.010 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1997 | 245 | 0.010 |
Why?
|
| Free Radicals | 1 | 1994 | 237 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1995 | 420 | 0.010 |
Why?
|
| Catalase | 1 | 1994 | 221 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 1624 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1681 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2001 | 1788 | 0.010 |
Why?
|
| Contrast Media | 1 | 2006 | 5300 | 0.010 |
Why?
|
| Cytokines | 1 | 2008 | 7323 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1998 | 1586 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1994 | 216 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 1581 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2010 | 40559 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2002 | 2108 | 0.010 |
Why?
|
| Leptin | 1 | 2000 | 1600 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18373 | 0.010 |
Why?
|
| Biological Transport | 1 | 1996 | 2120 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1994 | 596 | 0.010 |
Why?
|
| Endothelium, Corneal | 1 | 1993 | 199 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 1988 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4561 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1996 | 996 | 0.010 |
Why?
|
| Trypsinogen | 1 | 1990 | 86 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1991 | 457 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1994 | 1263 | 0.010 |
Why?
|
| Papio | 1 | 1991 | 656 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1991 | 338 | 0.010 |
Why?
|
| Nitrogen | 1 | 1990 | 344 | 0.010 |
Why?
|
| Cell Movement | 1 | 2001 | 5218 | 0.010 |
Why?
|
| Lipase | 1 | 1990 | 314 | 0.000 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1998 | 2938 | 0.000 |
Why?
|
| Myocardium | 1 | 2001 | 4772 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 17446 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1992 | 1536 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2010 | 41005 | 0.000 |
Why?
|
| Drinking | 1 | 1988 | 197 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1992 | 1537 | 0.000 |
Why?
|
| Sex Factors | 1 | 1981 | 10400 | 0.000 |
Why?
|
| Mitochondria | 1 | 1980 | 3514 | 0.000 |
Why?
|
| Tyrosine | 1 | 1991 | 1462 | 0.000 |
Why?
|
| Alleles | 1 | 1997 | 6933 | 0.000 |
Why?
|
| Atrophy | 1 | 1990 | 1584 | 0.000 |
Why?
|
| Acute Disease | 1 | 1996 | 7147 | 0.000 |
Why?
|
| Calcium | 1 | 1998 | 5755 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1987 | 1420 | 0.000 |
Why?
|
| Castration | 1 | 1984 | 159 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1984 | 919 | 0.000 |
Why?
|
| Incidence | 1 | 2001 | 20952 | 0.000 |
Why?
|
| Veins | 1 | 1987 | 770 | 0.000 |
Why?
|
| Skin | 1 | 1996 | 4372 | 0.000 |
Why?
|
| Genotype | 1 | 1997 | 12952 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1994 | 2134 | 0.000 |
Why?
|
| Autonomic Nervous System | 1 | 1986 | 672 | 0.000 |
Why?
|
| Immune Sera | 1 | 1980 | 641 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1990 | 3037 | 0.000 |
Why?
|
| Neural Crest | 1 | 1980 | 275 | 0.000 |
Why?
|
| Immunization, Passive | 1 | 1980 | 623 | 0.000 |
Why?
|
| Amino Acids | 1 | 1983 | 1737 | 0.000 |
Why?
|
| Antibodies | 1 | 1982 | 2460 | 0.000 |
Why?
|
| Prognosis | 1 | 1992 | 29060 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1992 | 53290 | 0.000 |
Why?
|